Literature DB >> 310166

Evaluation of the indirect hemagglutination technique for study of Trichomonas vaginalis infections, particularly in men.

T Kuberski.   

Abstract

The indirect hemagglutination (IHA) technique was evaluated for use in the serologic study of infection with Trichomonas vaginalis. The IHA test showed that sera from 88% of women attending a venereal disease clinic had antibody to T. vaginalis. The antibody frequency and titers were highest in women who had documented infections due to T. vaginalis. Serologic and cultural evidence of recent or active trichomonal infection was found in 11% of 85 men who had nongonococcal urethritis, but was absent in a control group of 27 men. Clinical findings in ten men with symptomatic genitourinary trichomoniasis are described; all but one had relatively high (greater than or equal to 1:80) IHA antibody titers. Antibody to T. vaginalis was found significantly (P less than 0.005) more often in sera from women than in sera from men in an apparently healthy group of individuals between the ages of 1 and 20 years. The IHA test appears potentially useful for the diagnosis of trichomoniasis in men and in the seroepidemiology of infections due to T. vaginalis.

Entities:  

Mesh:

Year:  1978        PMID: 310166     DOI: 10.1097/00007435-197807000-00004

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

1.  Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity.

Authors:  N Moav; E Draghi; A David; D Gold
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

2.  Venereal diseases in the islands of the North Pacific.

Authors:  R R Willcox
Journal:  Br J Vener Dis       Date:  1980-06

3.  Ankylosing spondylitis associated with Trichomonas vaginalis infection.

Authors:  T T Kuberski
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

4.  Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men.

Authors:  S Cornelia Kaydos-Daniels; William C Miller; Irving Hoffman; Topia Banda; Willard Dzinyemba; Francis Martinson; Myron S Cohen; Marcia M Hobbs
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

5.  Immunoglobulin isotypes of anti-Trichomonas vaginalis antibodies in patients with vaginal trichomoniasis.

Authors:  S M Wos; R M Watt
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

6.  Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis.

Authors:  M Cogne; P Brasseur; J J Ballet
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

7.  Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.

Authors:  Jennifer R Stark; Gregory Judson; John F Alderete; Vasanthakrishna Mundodi; Ashwini S Kucknoor; Edward L Giovannucci; Elizabeth A Platz; Siobhan Sutcliffe; Katja Fall; Tobias Kurth; Jing Ma; Meir J Stampfer; Lorelei A Mucci
Journal:  J Natl Cancer Inst       Date:  2009-09-09       Impact factor: 13.506

8.  Evaluation of two serological tests for Trichomonas vaginalis infection.

Authors:  H M Mathews; G R Healy
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

9.  Trichomonal vaginitis: evaluation of serological tests and identification of immunoreactive surface peptides.

Authors:  G Satapathy; S K Kar; J C Samantaray; S K Panda
Journal:  Genitourin Med       Date:  1988-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.